Cowen Prime Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2
Closed 212
2016
Q3
$0 Hold
2
﹤0.01% 254
2016
Q2
$0 Hold
2
﹤0.01% 235
2016
Q1
$0 Hold
2
﹤0.01% 242
2015
Q4
$0 Hold
2
﹤0.01% 243
2015
Q3
$0 Hold
2
﹤0.01% 261
2015
Q2
$0 Hold
2
﹤0.01% 281
2015
Q1
$0 Buy
+2
New +$206 ﹤0.01% 315
2014
Q4
Sell
-1
Closed 323
2014
Q3
$0 Hold
1
﹤0.01% 309
2014
Q2
$0 Hold
1
﹤0.01% 282
2014
Q1
$0 Hold
1
﹤0.01% 292
2013
Q4
$0 Hold
1
﹤0.01% 276
2013
Q3
$0 Hold
1
﹤0.01% 290
2013
Q2
$0 Buy
+1
New +$83 ﹤0.01% 275

Other funds holding LH

Cowen Prime Advisors's LH Position: Q4 2016 in Review

Cowen Prime Advisors sold out of Labcorp (LH) in Q4 2016, closing a stake of 2 shares.

Cowen Prime Advisors first reported a position in LH in Q2 2013 and held it in 13 quarters. The position peaked at $0 in Q3 2016. 696 funds tracked by Wall St. Rank hold LH as of Q4 2016.

  • Cowen Prime Advisors reported no remaining Labcorp position as of Q4 2016 after selling out during the quarter.
  • Cowen Prime Advisors sold 2 Labcorp shares in Q4 2016.
  • Cowen Prime Advisors first reported a position in Labcorp in Q2 2013 and held it in 13 quarters.
  • Cowen Prime Advisors's Labcorp position peaked at $0 in Q3 2016.
  • 696 funds tracked by Wall St. Rank held Labcorp as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.